- Healthcare Professionals
- Patients & Caregivers
- About AtriCure
Indication (Australia, Chile, EU Region, Kuwait, New Zealand, Saudi Arabia, UAE, UK)
The AtriCure Bipolar (Transpolar) System is indicated for ablation and coagulation of soft tissue in general, ENT, thoracic, urological, gynecological surgical procedures and ablation of cardiac tissue during surgery including pulmonary vein isolation and atrial connecting lesions for the Maze procedure for the treatment of cardiac arrhythmias, including atrial fibrillation.
Indication (Belarus, Russia)
The AtriCure Bipolar (Transpolar) System is intended to ablate cardiac tissue during surgery.
Indication (Japan)
The AtriCure Bipolar (Transpolar) System is intended for use in ablation of cardiac tissue during surgery by use of high-frequency current.
Indication (Singapore)
The AtriCure Bipolar (Transpolar) System is indicated for ablation of cardiac tissue during surgery including pulmonary vein isolation and atrial connecting lesions for the treatment of atrial fibrillation.
Indication (Canada)
The AtriCure Bipolar (Transpolar) System is intended to ablate cardiac tissue during surgery.